
Thermo Fisher Scientific SRD5A1 Polyclonal Antibody
SRD5A1 단백질을 표적하는 Thermo Fisher Scientific의 Goat Polyclonal Antibody. 인간 시료에 반응하며 IHC(P) 등 다양한 응용 가능. 고순도, 안정적인 액상 형태로 제공되며 -20°C에서 보관. 연구용으로만 사용 가능.
- 카탈로그번호
- PA5142132
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific SRD5A1 Polyclonal Antibody
Thermo Fisher Scientific SRD5A1 Polyclonal Antibody
Applications and Tested Dilution
- Immunohistochemistry (Paraffin) (IHC (P)): 5 µg/mL
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human |
| Host/Isotype | Goat / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen | Peptide with sequence ATATGVAEERLLC (aa 2–13) |
| Conjugate | Unconjugated |
| Form | Liquid |
| Concentration | 0.5 mg/mL |
| Purification | Ammonium sulfate precipitation |
| Storage Buffer | TBS, pH 7.3, with 0.5% BSA |
| Contains | 0.02% sodium azide |
| Storage Conditions | -20°C, Avoid Freeze/Thaw Cycles |
| Shipping Conditions | Wet ice |
| RRID | AB_2932790 |
Product Specific Information
This antibody is tested in Peptide ELISA: antibody detection limit dilution 1:128,000.
Target Information
Steroid 5alpha-Reductase is a key enzyme in androgen physiology, catalyzing the conversion of testosterone into the more potent 5alpha-dihydrotestosterone (DHT).
Two isoforms exist:
- Type 1: Expressed mainly in the skin
- Type 2: Expressed mainly in the prostate
5alpha-Reductase 1 is expressed in all portions of the hair follicle and in human breast carcinoma tissues, suggesting its role in local androgen production and potential involvement in cancer cell proliferation inhibition.
Additionally, the 5alpha-Reductase–3alpha-hydroxysteroid dehydrogenase complex is present in the human brain, indicating a possible role in neuroactive steroid synthesis or neurotoxic steroid metabolism.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
제품 이미지
(이미지 없음)
Thermo Fisher Scientific 상품 둘러보기
전체보기문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.
